Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Matthew T. Duvernay, Nizar Chahin et al.|The Lancet Neurology|2023Cited by 255
Pridopidine in Amyotrophic Lateral SclerosisPiera Pasinelli, Po-Ying Lai, H.Y. Chen et al.|JAMA|2025Cited by 17
CNM-Au8 in Amyotrophic Lateral SclerosisPiera Pasinelli, Po-Ying Lai, H. Chen et al.|JAMA|2025Cited by 11